Lineage Cell Therapeutics

Lineage Cell Therapeutics Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

08/06/2026

Lineage Cell Therapeutics reported second quarter 2026 financial results and will host a conference call at 4:30 pm ET / 1:30 pm PT today to provide a business update.

Learn more: https://bit.ly/4xtq2io

Lineage Cell Therapeutics thanks Drug Discovery World and editor Diana Turner for featuring CEO Brian Culley in the Summ...
07/22/2026

Lineage Cell Therapeutics thanks Drug Discovery World and editor Diana Turner for featuring CEO Brian Culley in the Summer 2026 issue.

Brian discusses the potential of cell replacement therapies in ophthalmology, including Lineage’s recently launched and wholly owned COR1 preclinical program for corneal endothelial disease, and its AlloSCOPE™ manufacturing platform. https://bit.ly/4pwHPT7

Lineage Cell Therapeutics wishes to thank Eyecelerator and distinguished moderators Allen Ho, MD, FACS, and SriniVas Sad...
07/21/2026

Lineage Cell Therapeutics wishes to thank Eyecelerator and distinguished moderators Allen Ho, MD, FACS, and SriniVas Sadda, MD, FARVO, for including the OpRegen® cell therapy program in the panel “Is Vision Improvement on the Horizon for Regenerative Medicine?” at Eyecelerator @ ARVO 2026.

Watch the full panel on YouTube: https://www.youtube.com/watch?v=wXamuo9kZjA

Genentech |

Lineage Cell Therapeutics will discuss progress with its COR1 preclinical program for corneal endothelial disease during...
07/13/2026

Lineage Cell Therapeutics will discuss progress with its COR1 preclinical program for corneal endothelial disease during a conference call today at 4:30 p.m. ET / 1:30 p.m. PT.

For more: https://bit.ly/4vv3qwC

07/06/2026

Lineage Cell Therapeutics announced that CEO Brian Culley will participate in a fireside chat hosted by Mayank Mamtani, Senior Managing Director, Group Head of Healthcare Research and Senior Biotechnology Analyst at B. Riley Securities, as part of the 2026 Mind, Muscle & Vision Healthcare Summit on July 16 in Boston.

For more: https://bit.ly/3R45Xzo

06/25/2026

Jill Howe, CFO of Lineage Cell Therapeutics, recently joined CFO Weekly to discuss how finance transformation in biotech starts with people, not platforms.

In the episode, Jill shares her perspective on streamlining procurement and clinical operations, building lean AP workflows, hiring for adaptability, and approaching AI as a practical tool for the finance function.

Listen to the full conversation:

Apple Podcasts: https://apple.co/4aorBoK
YouTube: https://bit.ly/4vxaUQw

Personiv |

Thank you to Retinal Physician and authors Jessica Randolph, MD, FASRS, and Ben Uzorka, for including OpRegen® in their ...
06/23/2026

Thank you to Retinal Physician and authors Jessica Randolph, MD, FASRS, and Ben Uzorka, for including OpRegen® in their review of the therapeutic pipeline for geographic atrophy (GA). The article highlights several clinical-stage approaches being explored in GA, including cell therapy.

Read the full article: https://bit.ly/3QYhIra

Thank you to CTS Retina and Arshad M. Khanani for hosting Lineage Cell Therapeutics CEO Brian Culley as part of the “Fro...
06/15/2026

Thank you to CTS Retina and Arshad M. Khanani for hosting Lineage Cell Therapeutics CEO Brian Culley as part of the “From Innovation to Approval: Bringing Novel Treatments to Market” panel at Clinical Trials at the Summit 2026.

06/10/2026

Lineage Cell Therapeutics announced that CEO Brian Culley will present as part of the “From Innovation to Approval: Bringing Novel Treatments to Market” panel at Clinical Trials at the Summit (CTS Retina ) 2026.

The session will be moderated by Pravin Dugel, M.D., Executive Chairman, President, and CEO of Ocular Therapeutix, and will include executive presenters from AbbVie, Oculis, Valitor Bio, Pharmaceuticals, RecensMedical, and others.

Learn more about the conference: https://www.ctsretina.org/

Address

2173 Salk Avenue, Suite 200
Carlsbad, CA
92008

Alerts

Be the first to know and let us send you an email when Lineage Cell Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Lineage Cell Therapeutics:

Shortcuts

Share